MedPath
HSA Approval

OXYTOCIN GRINDEKS SOLUTION FOR INJECTION AND INFUSION 10 IU/ML

SIN17068P

OXYTOCIN GRINDEKS SOLUTION FOR INJECTION AND INFUSION 10 IU/ML

OXYTOCIN GRINDEKS SOLUTION FOR INJECTION AND INFUSION 10 IU/ML

August 23, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

H01BB02

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HBM Pharma s.r.o.

Active Ingredients

Oxytocin

10iu/mL

Oxytocin

Documents

Package Inserts

Oxytocin Grindeks Solution for Injection and Infusion 10IU_ml PI.pdf

Approved: August 23, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OXYTOCIN GRINDEKS SOLUTION FOR INJECTION AND INFUSION 10 IU/ML - HSA Approval | MedPath